OTC Markets EXMKT - Delayed Quote USD

Biome Grow Inc. (BIOIF)

0.0005
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
Loading Chart for BIOIF
  • Previous Close 0.0000
  • Open 0.0005
  • Bid 0.0005 x --
  • Ask 0.0108 x --
  • Day's Range 0.0005 - 0.0005
  • 52 Week Range 0.0005 - 0.0200
  • Volume 9,000
  • Avg. Volume 258
  • Market Cap (intraday) 405,637
  • Beta (5Y Monthly) -1.50
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date Feb 12, 2025 - Feb 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Biome Grow Inc. focuses on the cannabis business. Biome Grow Inc. is headquartered in Toronto, Canada.

www.biomegrow.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BIOIF

View More

Performance Overview: BIOIF

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

BIOIF
86.84%
S&P/TSX Composite index (^GSPTSE)
2.99%

1-Year Return

BIOIF
91.74%
S&P/TSX Composite index (^GSPTSE)
13.33%

3-Year Return

BIOIF
97.64%
S&P/TSX Composite index (^GSPTSE)
26.79%

5-Year Return

BIOIF
98.96%
S&P/TSX Composite index (^GSPTSE)
69.43%

Compare To: BIOIF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BIOIF

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    56.21k

  • Enterprise Value

    3.02M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -48.75%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -2.13M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    56.36k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -215.38k

Research Analysis: BIOIF

View More

Company Insights: BIOIF

Research Reports: BIOIF

View More

People Also Watch